PDE10A Inhibition in Schizophrenia: A Randomised, Placebo-Controlled Phase 2 Study of Alofropodect (CPL&#39;36) in Patients Experiencing Acute Schizophrenia.

alofropodect (CPL'36) - Celon Pharma

http://www.ncbi.nlm.nih.gov/pubmed/42533223

Ewa Gromniak-Haniecka; Janos M Rethelyi; Joanna Sierzputowska-Prarat; Maciej Wieczorek; Mykhaylo Pustovoyt; Napoleon Waszkiewicz; Piotr J Rudzki; Sylwia Janowska; Yuliya Blazhevych; Yuriy Filts

Jul 31, 2026